Mayo Clinic (Rochester)
Rochester, MN
Filters
- PI3K Inhibitor
- Tyrosine Kinase (TK) Inhibitor
- Phase 2
Accepting patients
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Learn more- Phase 2
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
ON-TRK
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body (ON-TRK)
Learn more- Tyrosine Kinase (TK) Inhibitor
Filters
Save & Share
Advanced Filters
Trial Enrollment Status
Phase
Trial Type
Hide Treatments I've Had
This option allows you to hide trials that include all treatments that you have already received.